1. Home
  2. KTTA vs RCG Comparison

KTTA vs RCG Comparison

Compare KTTA & RCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.72

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

RCG

RENN Fund Inc

HOLD

Current Price

$3.24

Market Cap

18.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
RCG
Founded
2020
N/A
Country
United States
United States
Employees
4
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
18.1M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
KTTA
RCG
Price
$0.72
$3.24
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
345.2K
10.1K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$2.11
52 Week High
$2.34
$3.31

Technical Indicators

Market Signals
Indicator
KTTA
RCG
Relative Strength Index (RSI) 40.93 67.52
Support Level $0.67 $2.51
Resistance Level $0.77 $3.31
Average True Range (ATR) 0.06 0.08
MACD -0.01 -0.00
Stochastic Oscillator 58.89 93.36

Price Performance

Historical Comparison
KTTA
RCG

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

About RCG RENN Fund Inc

RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.

Share on Social Networks: